197 related articles for article (PubMed ID: 17558349)
1. Increased plasma levels of soluble triggering receptor expressed on myeloid cells 1 and procalcitonin after cardiac surgery and cardiac arrest without infection.
Adib-Conquy M; Monchi M; Goulenok C; Laurent I; Thuong M; Cavaillon JM; Adrie C
Shock; 2007 Oct; 28(4):406-10. PubMed ID: 17558349
[TBL] [Abstract][Full Text] [Related]
2. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis.
Gibot S; Cravoisy A; Kolopp-Sarda MN; Béné MC; Faure G; Bollaert PE; Levy B
Crit Care Med; 2005 Apr; 33(4):792-6. PubMed ID: 15818107
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of soluble triggering receptor expressed on myeloid cells-1 in critically-ill, postoperative patients with suspected sepsis.
Li L; Zhu Z; Chen J; Ouyang B; Chen M; Guan X
Am J Med Sci; 2013 Mar; 345(3):178-84. PubMed ID: 22739556
[TBL] [Abstract][Full Text] [Related]
4. Serum soluble triggering receptor expressed on myeloid cells-1 and procalcitonin can reflect sepsis severity and predict prognosis: a prospective cohort study.
Li Z; Wang H; Liu J; Chen B; Li G
Mediators Inflamm; 2014; 2014():641039. PubMed ID: 24672147
[TBL] [Abstract][Full Text] [Related]
5. Value of sTREM-1, procalcitonin and CRP as laboratory parameters for postmortem diagnosis of sepsis.
Palmiere C; Bardy D; Mangin P; Augsburger M
J Infect; 2013 Dec; 67(6):545-55. PubMed ID: 24012914
[TBL] [Abstract][Full Text] [Related]
6. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study.
Su L; Han B; Liu C; Liang L; Jiang Z; Deng J; Yan P; Jia Y; Feng D; Xie L
BMC Infect Dis; 2012 Jul; 12():157. PubMed ID: 22809118
[TBL] [Abstract][Full Text] [Related]
7. Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: a prospective study.
Zhang J; She D; Feng D; Jia Y; Xie L
BMC Infect Dis; 2011 Mar; 11():53. PubMed ID: 21356122
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of dynamics serum sCD163, sTREM-1, PCT, and CRP in differentiating sepsis, severity assessment, and prognostic prediction.
Su L; Feng L; Song Q; Kang H; Zhang X; Liang Z; Jia Y; Feng D; Liu C; Xie L
Mediators Inflamm; 2013; 2013():969875. PubMed ID: 23935252
[TBL] [Abstract][Full Text] [Related]
9. Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases.
Lin CH; Hsieh SC; Keng LT; Lee HS; Chang HT; Liao WY; Ho CC; Yu CJ
PLoS One; 2016; 11(4):e0153938. PubMed ID: 27096761
[TBL] [Abstract][Full Text] [Related]
10. Measurement of plasma sTREM-1 in patients with severe sepsis receiving early goal-directed therapy and evaluation of its usefulness.
Jeong SJ; Song YG; Kim CO; Kim HW; Ku NS; Han SH; Choi JY; Kim JM
Shock; 2012 Jun; 37(6):574-8. PubMed ID: 22395243
[TBL] [Abstract][Full Text] [Related]
11. High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis.
Huang CT; Lee LN; Ho CC; Shu CC; Ruan SY; Tsai YJ; Wang JY; Yu CJ
J Infect; 2014 May; 68(5):440-7. PubMed ID: 24393650
[TBL] [Abstract][Full Text] [Related]
12. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study.
Kofoed K; Andersen O; Kronborg G; Tvede M; Petersen J; Eugen-Olsen J; Larsen K
Crit Care; 2007; 11(2):R38. PubMed ID: 17362525
[TBL] [Abstract][Full Text] [Related]
13. Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock.
Ríos-Toro JJ; Márquez-Coello M; García-Álvarez JM; Martín-Aspas A; Rivera-Fernández R; Sáez de Benito A; Girón-González JA
PLoS One; 2017; 12(4):e0175254. PubMed ID: 28380034
[TBL] [Abstract][Full Text] [Related]
14. Soluble Triggering Receptor Expressed on Myeloid Cells-1 as a Novel Marker for Abdominal Sepsis.
Song X; Song Y; Zhang X; Xue H
Surg Infect (Larchmt); 2017 Jul; 18(5):577-581. PubMed ID: 28266902
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic value of procalcitonin and sTREM-1 levels in sepsis.
Halim B; Özlem T; Melek Ç; Münip Hakan Y; Cevval U; Gönül DH; Çiğdem Banu Ç
Turk J Med Sci; 2015; 45(3):578-86. PubMed ID: 26281323
[TBL] [Abstract][Full Text] [Related]
16. Values for serum procalcitonin, C-reactive protein, and soluble triggering receptor expressed on myeloid cells-1 in predicting survival of patients with early-onset stroke-associated pneumonia.
Xie J; Zhang XH; Zhu WY
Genet Mol Res; 2015 May; 14(2):4716-23. PubMed ID: 25966246
[TBL] [Abstract][Full Text] [Related]
17. PCT and sTREM-1: the markers of infection in critically ill patients?
Schultz MJ; Determann RM
Med Sci Monit; 2008 Dec; 14(12):RA241-7. PubMed ID: 19043381
[TBL] [Abstract][Full Text] [Related]
18. Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis.
Gibot S; Cravoisy A; Dupays R; Barraud D; Nace L; Levy B; Bollaert PE
Scand J Infect Dis; 2007; 39(6-7):604-8. PubMed ID: 17577825
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) to predict risk profile, response to antimicrobial therapy, and development of complications in patients with chemotherapy-associated febrile neutropenia: a pilot study.
Kwofie L; Rapoport BL; Fickl H; Meyer PW; Rheeder P; Hlope H; Anderson R; Tintinger GR
Ann Hematol; 2012 Apr; 91(4):605-11. PubMed ID: 21976106
[TBL] [Abstract][Full Text] [Related]
20. Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.
Xiao Y; Luo H; Zhou B; Dai X; Huang J; Duan L; You Y; Zhang W; Zhao H; Xie Y; Zhou Y; Ning W; Li T; Liu S; Zhu H; Xie X; Jiang Y; Wu S; He W; Li Y
Rheumatol Int; 2017 Apr; 37(4):585-592. PubMed ID: 27878344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
